FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77359
News■ Unclear/unknown
An amendment to EUDA Health (EUDA)'s governing documents was filed on October 5, 2026.
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A governing-document amendment is an administrative filing with no disclosed operational or financial change.
Routine governance filing, no signal
CATALYST TO WATCH
None identifiable from text
MAIN RISK
No material information disclosed
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Bambusa, Aspen and Tang added to IPO pipeline - pharmaphorum2026-10-13 10:51 UTC
Bambusa, Aspen and Tang added to IPO pipeline - pharmaphorum2026-10-13 10:51 UTC
→CORRELATIONshares Healthcare
AMSURG Partners with Euclid Endoscopy Center to Expand Access to Care in San Diego County2026-10-13 11:00 UTC
AMSURG Partners with Euclid Endoscopy Center to Expand Access to Care in San Diego County2026-10-13 11:00 UTC
→CORRELATIONshares Healthcare
Jocasta Neuroscience and Diamond Therapeutics Announce Research Program to Explore Non-Hallucinogenic Psychedelic-Inspired Compounds for Cognitive Impairment and Neurodegeneration2026-10-13 11:00 UTC
Jocasta Neuroscience and Diamond Therapeutics Announce Research Program to Explore Non-Hallucinogenic Psychedelic-Inspired Compounds for Cognitive Impairment and Neurodegeneration2026-10-13 11:00 UTC
→CORRELATIONshares Healthcare
RED QUEEN BIO APPOINTS IAN WATSON AS CHIEF GOVERNMENT AFFAIRS OFFICER2026-10-13 11:05 UTC
RED QUEEN BIO APPOINTS IAN WATSON AS CHIEF GOVERNMENT AFFAIRS OFFICER2026-10-13 11:05 UTC
→CORRELATIONshares Healthcare
125,000 restricted shares accompany FibroBiologics (FBLG)'s convertible debt offering.2026-10-13 10:03 UTC
125,000 restricted shares accompany FibroBiologics (FBLG)'s convertible debt offering.2026-10-13 10:03 UTC
→CORRELATIONshares Healthcare
Kelun-Biotech to Present Multiple Study Results at ESMO 20262026-10-13 11:18 UTC
Kelun-Biotech to Present Multiple Study Results at ESMO 20262026-10-13 11:18 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.